Metabolic syndrome (MetS) is a state of metabolic dysregulation and predisposes individuals to cardiovascular disease (CVD), stroke, and diabetes mellitus (DM). MS comprises three of five components, including central obesity, high fasting plasma glucose (FPG), hypertension, and dyslipidemia (high triglyceride [TG] and low high-density lipoprotein cholesterol [HDL-C] levels). It correlates with systemic inflammation. Visceral adipose tissue in central obesity secretes a variety of bioactive substances termed adipocytokines, such as adiponectin, leptin, resistin, tumor necrosis factor-α, interleukin (IL)-1, IL-6, IL-8, C-reactive protein, angiotensin II, and plasminogen activator inhibitor 1, which are most prevalent in the inflammatory response. They affect the entire body and contribute to low-grade systemic and vascular inflammation. These adipocytokines induce insulin resistance (IR) and thrombogenic vascular diseases. Periodontitis, major source of oral inflammation, has been reported to be associated in a range of systemic diseases, including the final stages of MetS; CVD and DM. A relation of MetS to periodontitis has also been reported. The underlying biological mechanisms for the association of MetS with periodontitis are not well known; however, adipose-tissue-derived cytokines may play an important role. This results in MetS patients being more at risk to the effects of microbial plaques, which in turn may modulate the severity of periodontitis. Nevertheless, all previous studies were performed in MetS patients who were uncontrolled and being on medication. MetS patients undergoing treatment with antihypertensive or antidyslipidemic drugs had decreased salivary flow rate from medication side effects that could affect the oral environment, plaque deposits, and periodontal disease. Individuals with hyposalivation condition had a higher number of decayed teeth and a higher prevalence of periodontitis than individuals with normal salivation. To preclude these effects, thus, this study was operated to evaluate whether periodontitis is associated with MetS, particularly in untreated condition, plasma adiponectin, and leptin among Thai people.
One hundred twenty five participants (35-76 years old) were recruited in the present study. Demographic and biological data were retrieved. Age, gender, smoking habit, alcohol consumption, frequency of tooth brushing, exercise and education level were noted. Levels of TG, HDL-C, FPG, and blood pressure (BP) were evaluated from medical chart records. Waist circumference (WC) was measured after the participants exhaled, using a measurement tape placed in the horizontal plane, midway between the inferior margin of the ribs and the superior border of the iliac crest. MetS was diagnosed when three of the following five factors were present. These included (1) elevated WC (≥85 cm in Thai males and ≥80 cm in Thai females), (2) elevated TG levels (≥150 mg/dL), (3) reduced HDL-C levels (<40 mg/dL in males and <50 mg/dL in females), (4) elevated BP (systolic BP≥ 130 or diastolic BP≥85 mmHg), and (5) elevated FPG levels (≥100 mg/dL). Although drug treatment for abnormalities in items (2) to (5) is an alternate indicator, MetS with these drugs were excluded from this study. Bleeding on probing (BOP), probing depth (PD), and clinical attachment level (CAL) of all teeth were examined with standard method to accurately provide the diagnosis of periodontitis. Two models for diagnosis of periodontitis were used: (1) according to the clinical criteria suggested by the American Academy of Periodontology (AAP) where CAL ≥3 mm is classified as moderate to severe periodontitis; and (2) the latest consensus for periodontal disease research defining periodontitis with a minimum diagnostic threshold at a given site where PD is ≥4 mm. Potential confounders were obtained by interview using structured questionnaires. Information on education level (lower or university Bachelor/higher) and personal habits (smoking and alcohol consumption: never, former, and current), as well as oral health behavior (frequency of tooth brushing), was collected. The frequency of tooth brushing was divided into three categories: (1) ≤1 time daily; (2) 2 times daily; and (3) ≥3 times daily. Plasma adiponectin and leptin levels were measured by enzyme-linked immunosorbent assay (ELISA). The human adiponectin and leptin commercial ELISA kit was used and each sample of plasma was analyzed in duplicate. Logistic regression analysis was used to calculate the odd ratios (ORs) and 95% confidence intervals (CIs). A p value of <.05 was considered as statistical significance.
Forty-four participants (35.2%) were healthy and 81 (64.8%) had MetS. All periodontal conditions (BOP, PD, and CAL) were significantly worse in MetS patients than healthy participants. MetS and an increased number of components were associated with average percentage of BOP, mean PD and mean CAL. After adjustment for confounders, in the severe periodontitis model determined by CAL, MetS was strongly associated with severe periodontitis (OR=3.60, 95% CI: 1.34-9.65). While in moderate to severe periodontitis model determined by BOP and PD, the OR was more apparent (6.94, 95% CI: 1.62-29.80). This association showed a dose-effect relationship. Patients with four to five components of MetS had a higher risk of periodontitis than patients with three components (OR=5.49, 95% CI: 1.75-17.19), while each separate component had no association with periodontitis, except for high diastolic blood pressure. Diastolic BP ≥85 mmHg had an effect on moderate to severe periodontitis though OR was in broad range (OR=53.22, 95% CI: 3.22-89.79). Periodontitis was also associated with age (OR=1.08, 95% CI: 1.01-1.14) and education (OR=3.76, 95% CI: 1.05-13.40). Because diabetes and smoking are well-known risk factors for periodontitis, subgroup analysis was conducted to exclude MetS patients with DM and smokers. Comparable results of association between MS and periodontitis were still obtained. Additionally, the risk of MS was predicted by body mass index and plasma adiponectin (OR=1.90, ). This indicated that there was a 7% decrease in the odds of having MetS for each 1 μg/ml increase in plasma adiponectin levels. None of the periodontal conditions were statistically significant for prognosis of MetS Although cause-effect interpretations has not been yielded from this study due to limitation of cross-sectional study. This study highlights the possible impact of MetS on periodontal health after adjusting for potential confounders. There may be a relationship between untreated MetS and moderate to severe periodontitis in Thai people. Moreover, MetS patients with a higher number of components are more strongly associated with periodontitis. For physician role, referral of patients for periodontal diagnosis should be regularly conducted in MS patients. Likewise, dentists should take MS into consideration when evaluating periodontal disease. Improvement of collaboration among dentists and physicians is required. 
